3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
9
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Hepatocellular
6
Recurrence
5
Pancreatic Neoplasms
5
Neoplasms
5
Stomach Neoplasms
4
Solid Tumor
4
Melanoma
4
Liver Neoplasms
4
Advanced Solid Tumors
4
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Leukemia, Myeloid, Acute
3
Biliary Tract Neoplasms
3
Advanced Solid Tumor
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Thoracic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Lung Cancer
1
Interventions
atezolizumab
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Locally Advanced or Metastatic Solid Tumors
×
Injections
×
Clear all
NCT05957471
2023-07-24
BC3195
Biocity Biopharmaceutics Co., Ltd.
Phase 1
Unknown
27 enrolled